This One HFpEF Group May Benefit From Diuretic After All

]]>(MedPage Today) -- There is one high-risk phenotype of heart failure with preserved ejection fraction (HFpEF) in particular that may benefit from spironolactone therapy, according to an analysis of the TOPCAT trial.Patients in the troubled trial...